E-Learning could sharpen Doctors' eye for skin cancer
NCT ID NCT07757386
First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time
Summary
This trial tests whether an online training course, called MelaMEd, can improve primary care doctors' ability to detect and manage melanoma, the most serious form of skin cancer. Participants—general practitioners, trainees, and pediatricians—answer questions and review skin lesion images before and after completing the course. Researchers compare the results to see if the training boosts knowledge, diagnostic accuracy, and appropriate referral decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- MelaMEd online training program
- What this could lead to
- If effective, this training could improve early melanoma detection and referral decisions in primary care, potentially saving lives.
- What could go wrong
- This is a single-group study without a comparison group, so improvements may not be solely due to the training. Results may not generalize beyond the participating doctors.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CUTANEOUS MELANOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Clinica Dermatologica, Fondazione IRCCS Policlinico San Matteo Pavia, Università degli Studi di Pavia, Pavia
Pavia, Lombardy, 27100, Italy
-
Dermatology and Dermosurgery Unit, San Giuseppe Moscati Hospital
Avellino, Campania, 83100, Italy
-
Dipartimento di Medicina, Chirurgia e Farmacia, Università di Sassari, Sassari
Sassari, Sardinia, 07100, Italy
-
Divisione di Dermatologia Cesena/Forlì AUSL Romagna e Dipartimento di Medicina e Chirurgia, Università di Bologna
Cesena, Emilia-Romagna, 47521, Italy
-
Istituto Dermopatico dell'Immacolata (IDI)-IRCCS, Roma
Rome, Lazio, 00167, Italy
-
Melanoma Skin Centre, ASST dei Sette Laghi, Ospedale di Circolo e Fondazione Macchi
Varese, Lombardy, 21100, Italy
-
SC Dermatologia, Dipartimento di Medicina e Chirurgia, Università di Parma, Parma
Parma, Emilia-Romagna, 43126, Italy
-
Section of Dermatology and Infectious Diseases, University of Ferrara
Ferrara, Emilia-Romagna, 44121, Italy
-
Unità di Dermatologia, ASST Papa Giovanni XXIII Ospedale di Bergamo, Bergamo
Bergamo, Lombardy, 24127, Italy
-
Unità di Dermatologia, Azienda Socio Sanitaria Territoriale (ASST) Lecco, Ospedale Alessandro Manzoni, Lecco
Lecco, Lombardy, 23900, Italy
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new drug tame advanced solid tumors?
- Can a short Pre-Surgery immunotherapy course replace Long-Term adjuvant treatment for melanoma?
- Can a single tracer light up cancer's first stop? a trial puts a hybrid dye-and-radioactive marker to the test.
- Could a Two-Drug combo reawaken the immune system against resistant cancers?
- Could starting immunotherapy earlier improve outcomes for High-Risk melanoma?
- Could a Two-Drug punch wipe out melanoma before surgery?